Sequence Similarity Clusters for the Entities in PDB 1I8I

Entity #1 | Chains: A
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN protein, length: 107 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 48270
95 % 2 2 36055 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 2 2 34410
70 % 2 2 30579
50 % 146 315 23
40 % 443 963 5
30 % 492 1093 7
Entity #2 | Chains: B
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN protein, length: 124 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 47297
95 % 2 2 35375 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 2 2 33773
70 % 198 402 9
50 % 279 603 7
40 % 444 963 5
30 % 493 1093 7
Entity #3 | Chains: C
EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII PEPTIDE ANTIGEN protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 5IVN 1 A BC2-nanobody 30538
3 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
4 5E7B 1 A nanobody nano-L06 9838
5 2P45 2 B ANTIBODY CAB-RN05 9838
6 2X1Q 1 A, B GELSOLIN NANOBODY 9844
7 5U64 1 B VHH-28 9838
8 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
9 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
10 4B41 1 A, B ANTIBODY G7 9844
11 5IMM 1 B Nanobody 9835
12 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
13 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
14 5NLU 1 A single domain llama antibody Nb36 9844
15 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
16 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
17 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
18 5IMK 1 B Nanobody 9835
19 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
20 4B50 1 A 2H10 LLAMA VHH 9844
21 2XT1 2 B CAMELID VHH 9 30538
22 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
23 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
24 5J1S 3 C VHH domain BS-2 30538
25 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
26 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
27 5L6Q 1 A, B H5AL 9606
28 5J1T 3 C VHH domain BS-2 30538
29 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
30 2X1O 1 A, B GELSOLIN NANOBODY 9844
31 4QGY 1 A, B nanobody n25, VH domain 9844
32 5C2B 1 H scFv 3B4 heavy chain 9606
33 5C2B 2 L 3B4 light chain 9606
34 5VNV 1 A Nb.b201 32630
35 5DXW 1 A PD-L1 nanobody 10090
36 3T0W 1 A, B immunoglobulin variable lambda domain 9606
37 4N9O 2 B Nanobody Nb484 Nb484 9844
38 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
39 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
40 3T0V 1 A immunoglobulin variable lambda domain 9606
41 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
42 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
43 1T2J 1 A M12-Variable Heavy domain 9606
44 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
45 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
46 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
47 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
48 1SQ2 2 N novel antigen receptor 7801
49 4KML 2 B Nanobody 9844
50 4Z9K 2 B VHH2(F5) antibody 30538
51 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
52 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
53 5LMW 1 A Nanobody 9844
54 5NM0 1 A, B, C, D Nb36 9844
55 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
56 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
57 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
58 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
59 4PPT 1 A Engineered single domain VHH antibody 9844
60 3R0M 1 A, B Llama VHH A12 9844
61 3ZKQ 2 D XA4813 9844
62 4I13 2 B Protein ca1697 (nanobody) 9844
63 5C2U 1 B Nanobody Nanobody 9838
64 1XFP 1 A heavy chain antibody VHH domain 9838
65 4POY 1 A VHH-metal 9844
66 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
67 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
68 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
69 5NLW 1 A nanobody Nb36 9844
70 3CDC 1 A, B Light Chain Amyloidogenic 9606
71 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
72 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
73 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
74 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
75 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
76 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
77 3G9A 2 B Minimizer 9838
78 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
79 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
80 2P43 2 B ANTIBODY CAB-RN05 9838
81 4KRN 1 A Nanobody/VHH domain EgA1 9844
82 4GFT 2 B Nanobody 9844
83 4TVS 2 a, b VHH Domain BS-1 30538
84 4W6Y 2 B Nanobody NbFedF9 9844
85 6EZW 1 B VHH antibody BCD090-M2 9844
86 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
87 1UAC 2 H Ig VH,anti-lysozyme 10090
88 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
89 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
90 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
91 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
92 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
93 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
94 5O02 2 C Nanobody (VHH) Nano-4 30538
95 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
96 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
97 4X7F 2 C, D Nano-25 Nanobody 30538
98 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
99 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
100 4LGR 2 B Camelid nanobody (VHH3) 30538
101 5J57 2 B VHH single chain antibody V5E1 30538
102 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
103 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
104 5OMM 2 C Nanobody (VHH) Nano-14 30538
105 5E03 1 A mouse CTLA-4 nanobody 10090
106 5LZ0 1 A, B PorM nanobody 9844
107 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
108 2XXC 1 B CAMELID VHH 9 30538
109 3QYC 1 A, B VH domain of IgG molecule 9606
110 5VAK 2 B Nb914 Nanobody 9844
111 2XXM 2 B CAMELID VHH 9 30538
112 5IR3 1 A Ig lambda chain V-VI region AR 9606
113 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
114 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
115 5JDS 1 B Nanobody 9835
116 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
117 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
118 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
119 5L8L 2 B New antigen receptor variable domain 168098
120 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
121 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
122 4AIZ 1 A, C, D V2-17 PROTEIN 9606
123 4AIZ 2 B V2-17 PROTEIN 9606
124 5L21 2 B VHH-C2 30538
125 5FWO 1 A NANOBODY 9844
126 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
127 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
128 4L1H 1 A Ig kappa chain V-I region Rei 9606
129 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
130 3B9V 1 A, B, C, D heavy chain variable domain 9606
131 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
132 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
133 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
134 5N88 1 A, H VH59 antibody 9606
135 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
136 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
137 3BD3 1 A, B catalytic antibody 10090
138 2OTU 1 A, C, E, G Fv light chain variable domain 10090
139 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
140 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
141 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
142 5L8J 2 B New antigen receptor variable domain 168098
143 1T6V 2 N, O novel antigen receptor 7801
144 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
145 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
146 4N1C 1 A, B immunoglobulin variable light chain domain 9606
147 4POU 2 B VHH Antibody 9844
148 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
149 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
150 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
151 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
152 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
153 2P42 2 B, D ANTIBODY CAB-RN05 9838
154 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
155 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
156 4QLR 1 A, B Llama nanobody n02 VH domain 9844
157 5J56 2 B VHH single chain antibody V1C7 30538
158 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
159 4NBX 2 B A20.1 VHH 9844
160 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
161 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
162 4HEP 2 G vHH17 domain 9844
163 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
164 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
165 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
166 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
167 5IML 2 B Nanobody 9835
168 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
169 3A6C 2 H IG VH, anti-lysozyme 10090
170 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
171 2DQD 2 H Ig VH,anti-lysozyme 10090
172 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
173 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
174 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
175 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
176 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
177 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
178 3A67 2 H IG VH, anti-lysozyme 10090
179 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
180 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
181 1J1X 2 H Ig VH,anti-lysozyme 10090
182 5L8K 2 B New antigen receptor variable domain 168098
183 5M2J 2 D Anti-(ED-B) scFV 9606
184 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
185 2DQC 2 H Ig VH,anti-lysozyme 10090
186 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
187 1J1O 2 H Ig VH,anti-lysozyme 10090
188 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
189 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
190 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
191 4M62 2 H, I GEP2 FV heavy chain 9606
192 5IVO 1 A BC2-nanobody 30538
193 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
194 1J1P 2 H Ig VH,anti-lysozyme 10090
195 4NBZ 2 B, D A26.8 VHH 9844
196 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
197 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
198 5AYU 2 H Ig VH,anti-lysozyme 10090
199 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
200 3A6B 2 H IG VH, anti-lysozyme 10090
201 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
202 2DQJ 2 H Ig VH,anti-lysozyme 10090
203 5F21 2 B nanobody MU375 9844
204 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
205 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
206 2P44 2 B ANTIBODY CAB-RN05 9838
207 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
208 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
209 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
210 5TP3 1 A, B F-VHH-4 9844
211 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
212 3B5G 1 A, B AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP residues 1-111 9606
213 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
214 4LHJ 2 B Camelid antibody 30538
215 4BEL 2 D, E XA4813 9844
216 5M7Q 1 A, B Nanobody NbD2 9838
217 5H8D 1 A VHH nanobody 9844
218 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
219 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
220 3DUR 1 A, C antibody Fv fragment SAG173-04 variable region fragment (Fv) 10090
221 3DUR 2 B, D Ig-like protein 10090
222 5T93 1 A, B, C, D ALT-05 immunoglobulin light chain variable domain from light chain amyloidosis patient last residue was not visible on electron density 9606
223 2XV6 2 B, D CAMELID VHH 9 30538
224 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
225 1LVE 1 A LEN, A VARIABLE DOMAIN FROM KAPPA-4 TYPE 9606
226 4ZG1 1 A, B, C, D, E, F NB17 9844
227 2IMM 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
228 4I1N 2 B Protein ca1697 (nanobody) 9844
229 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
230 5C9K 1 A, B, C, D, E, F, G, H Amyloid lambda 6 light chain variable region PIP 9606
231 6F0D 1 A, B VHH antibody BCD090-M2 9844
232 1FGV 1 L H52 FV (LIGHT CHAIN) 9606
233 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
234 4LCI 1 L anti canine CD28 antibody, 1C6, light chain 10090
235 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
236 4W6X 2 B Nanobody NbFedF7 9844
237 5JA9 2 A, B Nanobody 6 9844
238 1A7N 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
239 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
240 1CD0 1 A, B PROTEIN (JTO, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) IMMUNOGLOBULIN VARIABLE DOMAIN 9606
241 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
242 1OP9 1 A HL6 camel VHH fragment 9838
243 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
244 4LRN 1 H GEP 1 heavy chain 9606
245 4LRN 2 L GEP 1 light chain 9606
246 4S11 1 A GELSOLIN NANOBODY 9844
247 1EK3 1 A, B KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL, REC 9606
248 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
249 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
250 2YC1 2 B, E SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN 9606
251 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
252 6APQ 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
253 1SHM 1 A, B, D, E ANTIBODY RIG RIG VHH 9844
254 1G7H 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
255 1G7H 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
256 4Y7M 1 A, B Hi113 protein 9844
257 5JMO 2 C, D camelid VHH fragment 9838
258 1A7O 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
259 1A7O 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
260 1KIR 1 A MONOCLONAL ANTIBODY D1.3 10090
261 1KIR 2 B MONOCLONAL ANTIBODY D1.3 10090
262 4B5E 1 A, B PS2-8 9844
263 2DQE 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
264 2DQE 2 H Ig VH,anti-lysozyme 10090
265 1DVF 1 A FV D1.3 IGG1, KAPPA 10090
266 1DVF 2 B FV D1.3 IGG1, KAPPA 10090
267 1DVF 3 C FV E5.2 IGG1, KAPPA 10090
268 1DVF 4 D FV E5.2 IGG1, KAPPA 10090
269 1G7M 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
270 1G7M 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
271 4X7C 2 C, D Nano-85 Nanobody VHH 30538
272 1OAU 1 H, I, J, K IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
273 1OAU 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
274 1B0W 1 A, B, C BENCE-JONES KAPPA I PROTEIN BRE VARIABLE DOMAIN OF LIGHT CHAIN 9606
275 3EBA 1 A CAbHul6 9838
276 3ZHD 1 A, B MG8-4 SCAFFOLD ANTIBODY HUMAN HEAVY CHAIN DOMAIN 9606
277 1A6W 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
278 1A6W 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
279 1A7R 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
280 1A7R 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
281 1WZ1 1 L Ig light chain 10090
282 1WZ1 2 H Ig heavy chain Fv fragment(residues 1-123) 10090
283 3UPA 1 A, B kappa light chain variable domain 9606
284 4I0C 2 C, D cAbHuL5 antibody 9838
285 3LVE 1 A LEN KAPPA-IV LIGHT CHAIN DIMER 9606
286 1A7P 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
287 1A7P 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
288 4K3G 1 A, B immunoglobulin lambda variable domain L5(L89S) 9606
289 1XIW 3 C, G immunoglobulin light chain variable region 10090
290 1XIW 4 D, H immunoglobulin heavy chain variable region 10090
291 5NGV 2 H anti-human ActRIIB mAb BYM338 heavy-chain C-terminal His6-tag VH 9606
292 5NGV 3 L anti-human ActRIIB mAb BYM338 light-chain VL 9606
293 1A7Q 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
294 1A7Q 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
295 5BOP 1 A, C Nanobody 9844
296 4DKA 1 A, B single domain antibody VHH 9844
297 5O05 1 C, D Nanobody (VHH) Nano-42 30538
298 1OHQ 1 A, B IMMUNOGLOBULIN FV FRAGMENT, RESIDUES 1-120 9606
299 1DSF 1 L ANTICANCER ANTIBODY B1 FV 10090
300 1DSF 2 H ANTICANCER ANTIBODY B1 FV 10090
301 3DUU 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
302 3DUU 2 B, D Ig-like protein 10090
303 3BJ9 1 1 Immunoglobulin iota chain, Immunoglobulin lambda-like polypeptide 1 Fusion protein consists of Ig domain of VPREB protein and J-fragment of Ig lambda-5 9606
304 1H5B 1 A MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
305 1H5B 2 B, D MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
306 1H5B 3 C MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
307 3LRG 1 A, B anti-huntingtin VL domain anti-huntingtin VL domain 9606
308 3K74 2 B Nanobody 9844
309 5M15 2 C, D Synthetic nanobody L2_D09, (a-MBP#3) 32630
310 1KIP 1 A MONOCLONAL ANTIBODY D1.3 10090
311 1KIP 2 B MONOCLONAL ANTIBODY D1.3 10090
312 5LVE 1 A BENCE-JONES PROTEIN LEN G KAPPA CHAIN V-IV, VARIABLE DOMAIN, LIGHT CHAIN 9606
313 2EIZ 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
314 2EIZ 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
315 1SJV 1 A r9 llama VHH single domain antibody 9844
316 1PW3 1 A, B immunoglobulin lambda chain variable region 9606
317 4M3J 1 A, B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
318 5VL2 1 A, B, C, D, E, F, G, H T4 nanobody 9844
319 5JPJ 1 A, B 6aJL2 protein 9606
320 2UZI 1 H ANTI-RAS FV HEAVY CHAIN 9606
321 2UZI 2 L ANTI-RAS FV LIGHT CHAIN 9606
322 2I27 1 N, O New Antigen Receptor Ancestral variable domain 7801
323 3T0X 1 A, B Immunoglobulin variable lambda domain M8VLA4(S55P) 9606
324 1UA6 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
325 1UA6 2 H Ig VH,anti-lysozyme 10090
326 1IC7 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
327 1IC7 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
328 4W68 1 A, B Single domain antibody 9844
329 1JTT 1 A Vh Single-Domain Antibody VH domain fragment 9838
330 1CFV 1 L MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
331 1CFV 2 H MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
332 3EAK 1 A, B NbBCII10-FGLA 9838
333 1QP1 1 A, B, C BENCE-JONES KAPPA I ANTIBODY BRE (LIGHT CHAIN) IMMUNOGLOBULIN FRAGMENT, VARIABLE DOMAIN 9606
334 3U7A 1 A Amyloidogenic immunoglobulin light chain protein AL-09 Y32F Y96F, variable domain 9606
335 1KXT 2 B, D, F IMMUNOGLOBULIN VHH FRAGMENT 9838
336 4ORZ 3 C single domain antibody sdAb19 9844
337 4UU9 1 A, H MEDI7814 VARIABLE DOMAIN HEAVY CHAIN 9606
338 4UU9 2 B, L MEDI7814 VARIABLE DOMAIN LIGHT CHAIN 9606
339 3MOQ 1 A, B, C, D New antigen receptor variable domain,P3(40) peptide from Amyloid beta A4 protein,New antigen receptor variable domain CHIMERA OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN (RESIDUES 1-87 AND 102-113 FROM UNP Q6X1E6) INSERTED WITH AMYLOID BETA 18-41 (RESIDUES 689-712 FROM UNP P05067) 168098
340 6EY6 2 I, J, K, L, M, N, O, P nb130 9844
341 2VYR 2 E, F, G, H, I, J, K, L HUMAN SINGLE DOMAIN ANTIBODY 9606
342 1G7L 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
343 1G7L 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
344 1BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
345 1BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
346 5C1M 2 B Nanobody 39 9844
347 5F7K 2 C, D Nanobody Nb-ER19 9844
348 5LMJ 1 A, B, C, D nanobody 9844
349 5E1H 2 B F8(JOB10) VHH antibody 30538
350 1F2X 1 K, L ANTIBODY HEAVY CHAIN 9838
351 1IVL 1 A, B IGG-KAPPA M29B FV (LIGHT CHAIN) 10090
352 4OCM 3 C, F Nb1 9844
353 5HDO 1 A, B, C, D Anti-HCV NS3/4A serine protease immoglobulin heavy chain 9838
354 1A6U 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
355 1A6U 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
356 4X7E 2 C, D Nano-85 Nanobody 30538
357 5F1O 2 B nanobody MU551 9844
358 1ZV5 2 A immunoglobulin heavy chain antibody variable domain VHH D2-L29 9838
359 5O03 2 C, D Nanobody (VHH) Nano-32 11983
360 2DQI 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
361 2DQI 2 H Ig VH,anti-lysozyme 10090
362 1BRE 1 A, B, C, D, E, F BENCE-JONES KAPPA I PROTEIN BRE 9606
363 4Y8D 2 C, D nanobody 9844
364 3CX5 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
365 3CX5 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
366 4EIZ 2 C, D Nb113 Camel antibody fragment 9844
367 1I3U 1 A ANTIBODY VHH LAMA DOMAIN 9844
368 1I3V 1 A, B ANTIBODY VHH LAMA DOMAIN 9844
369 4C58 2 B NANOBODY 9844
370 5B8C 1 A, D, G, J Pembrolizumab light chain variable region (PemVL) 9606
371 5B8C 2 B, E, H, K Pembrolizumab heavy chain variable region (PemVH) 9606
372 3DV6 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
373 3DV6 2 B Ig-like protein 10090
374 1VES 1 A, B New Antigen Receptor variable domain 168098
375 4LAJ 3 H, I, L, M Llama single domain antibody, JM4 9844
376 2EKS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
377 2EKS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
378 3BD5 1 A, B catalytic antibody 10090
379 5VXM 2 B Single-domain antibody 20ipaD 30538
380 4XVJ 2 H antibody heavy chain variable domain 9606
381 4XVJ 3 L antibody light chain variable domain 9606
382 1AC6 1 A, B T-CELL RECEPTOR ALPHA VARIABLE DOMAIN 10090
383 4IDL 1 A Single Domain Antibody VHH A9 9844
384 1JV5 1 A Ig kappa chain precursor V region anti-blood group A Fv 9606
385 1JV5 2 B Ig chain heavy chain precursor V region 9606
386 1FVC 1 A, C IGG1-KAPPA 4D5 FV (LIGHT CHAIN) 9606
387 1FVC 2 B, D IGG1-KAPPA 4D5 FV (HEAVY CHAIN) 9606
388 3K7U 1 A Antibody 9844
389 4Z0X 1 A Antibody HC26AM light chain variable domain 9606
390 4Z0X 2 B Antibody HC26AM heavy chain variable domain 9606
391 1IC5 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
392 1IC5 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
393 4NBY 2 B, C A20.1 VHH 9844
394 4X7D 2 C, D Nano-85 Nanobody VHH 9844
395 5VAN 2 B Nb914 Nanobody 9844
396 2CD0 1 A, B PROTEIN (BENCE-JONES PROTEIN WIL, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) VARIABLE DOMAIN 9606
397 5F7N 2 C, D Nanobody Nb-ER19 30538
398 5OCL 1 A, C, F, H anti-llama nanobody 30538
399 5OCL 2 B, D, E, G anti-vglut nanobody 9844
400 4LAS 1 H Single heavy chain Variable fragment Heavy chain 10090
401 4LAS 2 L Single light chain Variable fragment Light Chain 10090
402 2A9M 1 L, M fluorescein-scfv light chain 9606
403 2A9M 2 H, I fluorescein-scfv heavy chain 9606
404 2YWZ 1 A new antigen receptor variable domain 168098
405 5E5M 2 B, D, F, H mouse anti CTLA-4 nanobody 10090
406 1SJX 1 A immunoglobulin VH domain 9844
407 3ZKS 2 D XA4813 9844
408 1A6V 1 L, M, N B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
409 1A6V 2 H, I, J B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
410 5MY6 2 B Nanobody 2Rs15d 9838
411 3DUS 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
412 3DUS 2 B, D Ig-like protein 10090
413 5NH3 2 H, I anti-human ActRIIB mAb BYM338 Fv heavy-chain 9606
414 5NH3 3 L, M anti-human ActRIIB mAb BYM338 Fv light-chain 9606
415 5M2I 2 G, H, I, J, K, L VHH1 9844
416 2COQ 1 A new antigen receptor variable domain 168098
417 5MWN 2 D, E, F llama nanobody raised against TssK, nbK18 9844
418 5MWN 3 N llama nanobody raised against TssK, nbK27 9844
419 3ZHK 1 A, B MG2X1 SCAFFOLD ANTIBODY 9606
420 3K1K 2 C, D Enhancer 9838
421 4U7S 1 A, B sdAb A3 9844
422 4U3X 1 A, C Human VH domain antibody 9606
423 4W81 1 A Single Domain Antibody 9844
424 5GRV 1 L homo-specific diabody heavy chain 9606
425 5GRV 2 K homo-specific diabody light chain 9606
426 5JMR 1 A, B camelid VHH fragment 9838
427 4W70 1 A Single Domain Antibody 9844
428 2GSG 1 A, C monoclonal antibody light chain variable domain 10090
429 2GSG 2 B, D monoclonal antibody heavy chain variable domain 10090
430 2W0L 1 A, B, C, D V1-22 PROTEIN 9606
431 5TBD 1 A, D, E, J Fv fragment (mAb4D1) heavy chain 10090
432 5TBD 2 B, F, G, K Fv fragment (mAb4D1) heavy chain 10090
433 4BFB 2 D, E XA4813 9844
434 5DHV 1 A Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
435 5DHV 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
436 5DHV 3 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
437 4LVE 1 A, B LEN KAPPA-IV LIGHT CHAIN DIMER 9606
438 43C9 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
439 43C9 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
440 1NMB 2 L FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
441 1NMB 3 H FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
442 5LHR 2 B Camelid-Derived Antibody Fragment Nb22 30538
443 1I8I 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
444 1I8I 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
445 1OAR 1 H, I, J, K IMMUNOGLOBULIN E FV, RESIDUES 1-122 10090
446 1OAR 2 L, M, N, O IMMUNOGLOBULING E FV, RESIDUES 1-110 10090
447 1D9K 1 A, E T-CELL RECEPTOR D10 (ALPHA CHAIN) 10090
448 4LHQ 2 B, D Camelid nanobody 30538
449 3DV4 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
450 3DV4 2 B Ig-like protein 10090
451 3ZKX 2 B XA4813 9844
452 3ZKX 3 C XA4815 9844
453 5F1K 2 C, D nanobody MU1053 9844
454 3ZLQ 2 C, D XA4813 9844
455 1I3G 1 L ANTIBODY FV FRAGMENT VL DOMAIN 10090
456 1I3G 2 H ANTIBODY FV FRAGMENT VH DOMAIN 10090
457 1DL7 1 L PROTEIN (ANTIBODY M3C65 (LIGHT CHAIN)) COMBINED LIGHT AND HEAVY CHAIN VIA (G4S)3 LINKER FV (SINGLE CHAIN) 10090
458 1DL7 2 H PROTEIN (ANTIBODY M3C65 (HEAVY CHAIN)) FV (SINGLE CHAIN) 10090
459 4NC0 2 B A26.8 VHH 9844
460 1OCW 1 H IMMUNOGLOBULIN E FV REGION, RESIDUES 1-121 10090
461 1OCW 2 L IMMUNOGLOBULIN E FV REGION, RESIDUES 1-120 10090
462 1IGM 1 L IGM-KAPPA POT FV (LIGHT CHAIN) 9606
463 1IGM 2 H IGM-KAPPA POT FV (HEAVY CHAIN) 9606
464 5GS1 1 A, M, O, Q light chain 9606
465 5GS1 2 B, N, P, R heavy chain 9606
466 5F7Y 3 C, D Nanobody Nb-ER19 9844
467 2DQG 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
468 2DQG 2 H Ig VH,anti-lysozyme 10090
469 5IMO 1 B Nanobody 9835
470 5U65 1 A, B VHH-5 9838
471 2PXY 1 A T cell receptor alpha chain 10090
472 3BDX 1 A, B, C Amyloid lambda 6 light chain variable region PIP (fragment) Residues 1-111 9606
473 4TYU 1 A, B Single Domain Antibody 9844
474 43CA 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
475 43CA 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
476 2DQH 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
477 2DQH 2 H Ig VH,anti-lysozyme 10090
478 4AQ1 2 B, D NBKB6 VHH 9844
479 6FV0 2 F nanobody 9844
480 2Q1E 1 A, B, C, D Amyloidogenic immunoglobulin light chain protein AL-09 9606
481 4EIG 2 B CA1698 camel antibody fragment 9844
482 3EHB 3 C FV fragment Chain H 10090
483 3EHB 4 D FV fragment Chain L 10090
484 3HB3 3 C ANTIBODY FV FRAGMENT 10090
485 3HB3 4 D ANTIBODY FV FRAGMENT 10090
486 4FFY 1 L DENV1-E111 single chain variable fragment (light chain) 10090
487 4FFY 2 H DENV1-E111 single chain variable fragment (heavy chain) 10090
488 4N1E 1 A, B, C, D, E, F, G, H immunoglobulin variable light chain domain 9606
489 2X89 1 A, B, C ANTIBODY 9838
490 5M2M 2 D, E, F, H, J, N Llama nanobody VHH3 9844
491 5O04 2 E, F Nanobody (VHH) Nano-26 30538
492 5O04 3 C, D Nanobody (VHH) Nano-85 30538
493 5LBS 2 H, I BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 ScFv fragment, heavy chain 9606
494 5LBS 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 SCFV fragment, light chain 9606
495 3P9W 2 B, D, F, H human VEGF 9606
496 1AP2 1 A, C MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
497 1AP2 2 B, D MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
498 5F8R 2 C, D Nanobody Nb-ER19 9844
499 1IC4 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
500 1IC4 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
501 4OCL 3 C, F Nb1 9844
502 3CDY 1 A, B IMMUNOGLOBULIN LIGHT CHAIN 9606
503 4RAV 1 B, D Single-chain Fv, VL 9606
504 4RAV 2 A, C single-chain Fv, VH 9606
505 5XJ4 2 H durvalumab-VH 9606
506 5XJ4 3 L durvalumab-VL 9606
507 5LWY 2 H V REGION HEAVY CHAIN 10090
508 5LWY 3 L V REGION LIGHT CHAIN 10090
509 1KB9 10 J HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
510 1KB9 11 K LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
511 4X4X 1 A, C Human Variable Heavy Chain of Herceptin 9606
512 4X4X 2 B, D Human Variable Light Chain of Herceptin 9606
513 2Z8V 2 C, D New antigen receptor variable domain 168098
514 4IOS 2 D, E, F, G Llama nanobody 11 9844
515 2W0K 1 A, B V1-22 PROTEIN 9606
516 5LHN 2 B Camelid-Derived Antibody Fragment Nb7 30538
517 2BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
518 2BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
519 2IBZ 10 X Variable Heavy chain of antibody fragment 10090
520 2IBZ 11 Y Variable Light chain of antibody fragment 10090
521 4K3H 1 A, B, C, D, E, F, G, H Immunoglobulin lambda variable domain L5(L89S) 9606
522 4C57 2 C, D NANOBODY 9844
523 3ZHL 1 A MG8-14 SCAFFOLD ANTIBODY 9606
524 2Z8W 2 C, D New antigen receptor variable domain 168098
525 4OCN 3 C, F Nb1 9844
526 4GRW 3 E, G Nanobody 124C4 9844
527 4GRW 4 F, J Nanobody 37D5 9844
528 4GRW 5 H, I Nanobody 22E11 9844
529 5G5R 2 B NANOBODY NB330 SELECTED FROM LLAMA GLAMA 9844
530 4NC2 2 B B39 VHH 9844
531 2WZP 2 D, E, F, J, K, L CAMELID VHH5 9844
532 5LHQ 2 B Camelid-Derived Antibody Fragment Nb7 30538
533 2OI9 2 B T cell receptor alpha chain 10090
534 4HGM 1 A Shark V-NAR 7797
535 3BD4 1 A, B catalytic antibody 10090
536 1WT5 1 A, B ANTI EGFR ANTIBODY FV REGION VH fragment 9606
537 1WT5 2 C, D ANTI EGFR ANTIBODY FV REGION VL fragment 9606
538 6EY0 2 E, G, H llama nanobody nb01 9844
539 6EY0 3 F llama nanobody nb01 9844
540 1JHL 1 L IGG1-KAPPA D11.15 FV (LIGHT CHAIN) 10090
541 1JHL 2 H IGG1-KAPPA D11.15 FV (HEAVY CHAIN) 10090
542 5F9A 2 C Nanobody Nb-ER19 9844
543 4LLV 1 A, C, E, H 4E10 Fv heavy chain 9606
544 4LLV 2 B, D, F, L 4E10 Fv light chain 9606
545 4LAR 1 H Single heavy chain variable fragment Heavy Chain 10090
546 4LAR 2 L Single light chain variable fragment Light Chain 10090
547 5CBA 1 A, C 3b4 heavy chain 9606
548 5CBA 2 B, D 3b4 light chain 9606
549 5VXJ 2 B, D, F, H, J single-domain antibody JMK-E3 30538
550 1A14 2 H NC10 FV (HEAVY CHAIN) VH DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
551 1A14 3 L NC10 FV (LIGHT CHAIN) VL DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
552 1C08 1 A ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VL FRAGMENT 10090
553 1C08 2 B ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VH FRAGMENT 10090
554 2OTW 1 A, C Fv light chain avriable domain VL 10090
555 2OTW 2 B, D Fv heavy chain variable domain VH 10090
556 3STB 1 A, B single domain antibody VHH 9844
557 2YSS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
558 2YSS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
559 4W6W 2 B NbFedF6 9844
560 5JA8 2 B, D, F, H Nanobody 2 9844
561 2YBR 1 A, D, G SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN, RESIDUES 1-117 9606
562 2YBR 2 B, E, H SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN, RESIDUES 118-263 9606
563 2I26 1 N, O, P New Antigen Receptor Ancestral variable domain 7801
564 2BJM 1 H IGE SPE7 HEAVY CHAIN ANTHRONE ATTACHED HEAVY CHAIN, RESIDUES 1-120 10090
565 2BJM 2 L IGE SPE7 LIGHT CHAIN LIGHT CHAIN, RESIDUES 1-110 10090
566 1P4B 1 L Antibody Variable light chain 10090
567 1P4B 2 H Antibody Variable heavy chain 10090
568 5U4M 2 B V1C7 VHH antibody 30538
569 5O0W 2 E, F, G, H Nb474 30538
570 4Y5V 1 A, D, G diabody 305 VH domain 9606
571 4Y5V 2 B, E, H Diabody 305 VL domain 9606
572 1I9E 1 A CYTOTOXIC TCELL VALPHA DOMAIN N-TERMINAL DOMAIN OF ALPHA CHAIN 10090
573 1DQL 1 L IGM MEZ IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN FRAGMENT 9606
574 1DQL 2 H IGM MEZ IMMUNOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN FRAGMENT 9606
575 1JTO 1 A, B Vh Single-Domain Antibody VH domain fragment 9838
576 3V0A 3 C Llama antibody F12 9844
577 2Z35 1 A T-cell receptor alpha-chain 10090
578 5F97 2 E, F, G, H Nanbody Nb-ER19 9844
579 3K80 1 A, B Antibody 9844
580 5VAQ 2 B Nb914 Nanobody 9844
581 1QD0 1 A VHH-R2 ANTI-RR6 ANTIBODY VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
582 5F8Q 2 C, D Nanobody Nb-ER19 9844
583 4U05 1 A, B Single Domain Antibody 9844
584 5F9D 2 C Nanobody Nb-ER19 9844
585 4X4Y 1 A, C Human Variable Heavy Chain of Herceptin 9606
586 4X4Y 2 B, D Human Variable Light Chain of Herceptin 9606
587 4LGP 2 B, D VHH1 camelid nanobody 30538
588 2P48 2 B ANTIBODY CAB-RN05 9838
589 5U4L 2 B V1C7 VHH antibody G29R variant 30538
590 5VXK 1 B single-domain antibody JMK-H2 30538
591 5F7M 2 C, D Nanobody Nb-ER19 9844
592 1VER 1 A New Antigen Receptor variable domain 168098
593 5DA4 1 A, B, C Nanobody recognizing the membrane protein SLC26Dg 9844
594 5F7W 2 C, D Nanobody Nb-ER19 9844
595 4YQX 1 H, N JES6-1 VH domain 10116
596 4YQX 2 L, O JES6-1 VL domain 10116
597 1FO0 4 A PROTEIN (BM3.3 T CELL RECEPTOR ALPHA-CHAIN) FV FRAGMENT, VARIABLE DOMAIN 10090
598 1EZV 10 X HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
599 1EZV 11 Y LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
600 3U6R 1 A, H Antibody 1:7 (Heavy chain) 9606
601 3U6R 2 B, L Antibody 1:7 (Light chain) 9606
602 1U3H 1 A, E T-cell receptor alpha-chain V2.3-J39-C 10090
603 1KTR 1 L Anti-his tag antibody 3d5 variable light chain 10090
604 1KTR 3 H Anti-his tag antibody 3d5 variable heavy chain 10090
605 2YWY 1 A, B, C, D new antigen receptor variable domain 168098
606 1NMC 2 B, H SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
607 1NMC 3 C, L SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
608 1KB5 1 A KB5-C20 T-CELL ANTIGEN RECEPTOR 24 RESIDUE LINK BETWEEN VALPHA C-TERMINUS AND VBETA N-TERMINUS FV FRAGMENT, VARIABLE DOMAIN 10090
609 1MEL 1 A, B VH SINGLE-DOMAIN ANTIBODY 9838
610 4NC1 2 C, D A20.1 VHH 9844
611 4NC1 3 E, F A26.8 VHH 9844
612 5M30 2 D, E, F Anti-vesicular stomatitis virus N VHH 30538
613 4WEU 1 D, E Anti-F4+ETEC bacteria VHH variable region 9844
614 2DQF 1 A, D lysozyme binding Ig kappa chain V23-J2 region 10090
615 2DQF 2 B, E Ig VH,anti-lysozyme 10090
616 1B88 1 A, B T CELL RECEPTOR V-ALPHA DOMAIN V-ALPHA DOMAIN 10090
617 5E7F 1 A, B, C nanobody L06 9838
618 2P46 2 B, D ANTIBODY CAB-RN05 9838
619 3CXH 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
620 3CXH 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
621 2E7L 1 A, B Cytotoxic Tcell receptor UNP RESIDUES 21-132 10090
622 5LWF 2 C, D Camelid heavy-chain antibody variable fragment cAb-G10S 9844
623 5LHP 2 B Camelid-Derived Antibody Fragment 30538
624 2ICW 5 I, K T-cell receptor alpha chain V residues 21-131 10090
625 5USF 2 C, D Immunoglobulin heavy chain variable region 9844
626 1P84 10 J Heavy Chain (Vh) Of Fv-Fragment 10090
627 1P84 11 K Light Chain (Vl) Of Fv-Fragment 10090
628 5SV4 1 A, B Single Domain Antibody A3C8 9844
629 4LGS 2 B Camelid nanobody (VHH4) 30538
630 3QXV 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
631 2XTJ 2 B FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
632 2XTJ 4 D FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-131 9606
633 5CBE 1 A, C E10 heavy chain 9606
634 5CBE 2 B, D E10 light chain 9606
635 2P47 2 B ANTIBODY CAB-RN05 9838
636 4KRM 2 B, D, F, H, J, L Nanobody/VHH domain 7D12 9844
637 3WXW 2 H V region heavy chain 10090
638 3WXW 3 L V region light chain 10090
639 3K3Q 1 A llama Aa1 VHH domain 9844
640 1F6L 1 L ANTI-FERRITIN IMMUNOGLOBULIN LIGHT CHAIN VARIABLE LIGHT CHAIN 9606
641 3LRH 1 A, C, E, G, I, K, M, O anti-huntingtin VL domain anti-huntingtin VL domain 9606
642 4P2C 3 G, H, I, J, K Nanobody 1, Anti-F4+ETEC bacteria VHH variable region 9844
643 1AR1 3 C ANTIBODY FV FRAGMENT 10090
644 1AR1 4 D ANTIBODY FV FRAGMENT 10090
645 3EZJ 2 B, D, F, H NANOBODY NBGSPD_7 9844
646 5VNW 2 C, D Nb.b201 32630
647 1BVK 1 A, D HULYS11 FV 9606
648 1BVK 2 B, E HULYS11 FV 9606
649 6FE4 2 F, G, H, I, J Nb113 30538
650 5FV1 1 L, M VK DOMAIN ANTIBODY VK DOMAIN ANTIBODY, RESIDUES 1-108 9606
651 5NML 1 A, B, C, D, E, F, G, H, I, J Nanobody Nb36 Ser85Cys 9844
652 2CJU 1 H NQ16-113.8 ANTI-PHOX ANTIBODY 10090
653 2CJU 2 L NQ16-113.8 ANTI-PHOX ANTIBODY 10090
654 5HVF 2 B VHH-i83 30538
655 1P4I 1 L ANTIBODY VARIABLE LIGHT CHAIN 10090
656 1P4I 2 H antibody variable heavy chain 10090
657 4PGJ 1 A, C Human heavy chain domain antibody 9606
658 2LVE 1 A RLEN KAPPA-IV LIGHT CHAIN DIMER 9606
659 4KDT 1 A, B Nanobody24 9835
660 3CFI 3 C, F, I, L Nanobody NBEPSIJ_11 9844
661 2VH5 1 H ANTI-RAS FV HEAVY CHAIN 9606
662 2VH5 2 L ANTI-RAS FV LIGHT CHAIN 9606
663 4S10 1 A, B GELSOLIN NANOBODY GELSOLIN NANOBODY 9844
664 5MJE 2 B Nanobody 8 9844
665 3LH2 2 H, I, J, K Fv 4E10 heavy chain 9606
666 3LH2 3 L, M, N, O Fv 4E10 light chain 9606
667 3OGO 2 E, F, G, H GFP-nanobody 9838
668 4C59 2 B NANOBODY 9844
669 5VXL 2 B single-domain antibody JPS-G3 30538
670 1OAZ 2 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
671 1OAZ 3 L, N IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
672 4DK6 1 A, B single domain antibody VHH 9844
673 5F93 2 C, D, F, H Nanobody Nb-ER19 9844
674 1CL7 2 H PROTEIN (IGG1 ANTIBODY 1696 (variable heavy chain)) FAB 10090
675 5F7L 2 B, D Nanobody Nb-ER14 9844
676 1KJ2 4 A, D KB5-C20 T-Cell receptor alpha-chain Fv fragment , variable domain 10090
677 1OAY 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
678 1OAY 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
679 5HVG 2 B, D VHH-a204 30538
680 4LAQ 1 H Single heavy chain variable fragment Heavy chain 10090
681 4LAQ 2 L Single light chain variable fragment Light Chain 10090
682 3UPC 1 A, B, C, D, E, F, G, H, I, J heavy chain variable domain 9606
683 4W2Q 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
684 5HVH 2 B VHH-a204 30538
685 5HVH 3 C VHH-i83 30538
686 4XT1 3 C nanobody 7 30538
687 5LXG 2 H V REGION HEAVY CHAIN 10090
688 5LXG 3 L V REGION LIGHT CHAIN 10090
689 5HM1 1 A, B, C lama VHH antibody 2E7 9844
690 5FUC 3 E, V VHH6 9838
691 4RZC 1 A, C, E, H Fv M6P-1 light chain 9986
692 4RZC 2 B, D, F, L Fv M6P-1 heavy chain 9986
693 3H3P 1 H, I Fv 4E10 heavy chain 9606
694 3H3P 2 L, M Fv 4E10 light chain 9606
695 5O2U 2 B, D VHH 59H10 9844
696 5SV3 1 A, C Anti-Ricin A-chain Single Domain Antibody (sdAb) A3C8 9844
697 3NN8 1 A, C, D, G Engineered scFv, heavy chain 10090
698 3NN8 2 B, E, F, H Engineered scFv, light chain 10090
699 5OMN 2 C Nanobody (VHH) Nano-27 30538
700 4KRP 2 B Nanobody/VHH domain 9G8 9844
701 1OAX 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
702 1OAX 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
703 4FHB 2 D Nb179 9844
704 4DK3 1 A, B single domain antibody VHH 9844
705 4KRL 1 B Nanobody/VHH domain 7D12 9844
706 4V1D 1 A SINGLE CHAIN ANTIBODY FRAGMENT LR, HEAVY CHAIN 9606
707 4V1D 2 B SINGLE CHAIN ANTIBODY FRAGMENT LR, LIGHT CHAIN 9606
708 4V1D 4 D SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN 9606
709 4V1D 5 E SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN 9606
710 2Z31 1 A T-cell receptor alpha-chain 10090
711 1BZQ 2 K, L, M, N PROTEIN (ANTIBODY CAB-RN05) VARIABLE DOMAIN 9838
712 1NMA 2 L FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
713 1NMA 3 H FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
714 1NAM 1 A BM3.3 T Cell Receptor alpha-Chain Fv Fragment, Variable Domain 10090
715 1YZZ 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 9838
716 4LDE 2 B Camelid Antibody Fragment 9844
717 4Y5Y 1 A, D diabody 330 VH domain 9606
718 4Y5Y 2 B, E diabody 330 VL domain 9606
719 5DMJ 2 B, E, G 3H65-5 domain antibody (dAb) 9606
720 1BVL 1 A, C HULYS11 FV 10090
721 1BVL 2 B, D HULYS11 FV 10090
722 3RJQ 2 B Llama VHH A12 9844
723 1ZMY 1 A Antibody cabbcII-10:lys3 N-terminus, 142 residues 9838
724 4UNT 1 A, B, C, D, E, F, G, H IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
725 3AB0 2 B, E antibody ScFv fragment, heavy chain 10090
726 3AB0 3 C, F antibody ScFv fragment, light chain 10090
727 3LHP 1 H, I Fv 4E10 heavy chain 9606
728 3LHP 2 L, M Fv 4E10 light chain 9606
729 4N1H 2 B, D Camelid heavy-chain antibody variable fragment cAb-F11N 9844
730 2BX5 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O VD9 VKI LIGHT-CHAIN LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
731 6CK9 2 D 35O22 scFv heavy chain portion 9606
732 6CK9 3 E 35O22 scFv light chain portion 9606
733 6EQI 2 B Nb696 9844
734 2BSE 2 D, E, F LLAMA IMMUNOGLOBULIN VHH RECOGNITION DOMAIN, RESIDUES 1-123 9844
735 1YC8 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33-hu 9838
736 4KFZ 2 C, D Anti-LMO2 VH 9606
737 2UUD 1 H, J NQ10-1.12 ANTI-PHOX ANTIBODY 10090
738 2UUD 2 K, L NQ10-1.12 ANTI-PHOX ANTIBODY 10090
739 5TOJ 2 D, E, F Single-domain antibody F-VHH-4 9844
740 4Y5X 1 A, D, G, J diabody 310 VL domain 9606
741 4Y5X 2 B, E, H, K diabody 310 VH domain 9606
742 4YGA 2 B, D, F, H VHH-1B7 30538
743 4UT9 2 H, I, J, K BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, HEAVY CHAIN DOMAIN 9606
744 4UT9 3 L, M, N, O BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, LIGHT CHAIN DOMAIN 9606
745 2A9N 1 L, M fluorescein-scfv light chain 9606
746 2A9N 2 H, I fluorescein-scfv heavy chain 9606
747 5XQY 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 Y96K mutant of REI VL 9606
748 5GS0 2 C, E light chain (anti-TLR3) 10090
749 5GS0 3 D, F heavy chain (anti-TLR3) 10090
750 5GS0 4 H, X heavy chain (anti-Lid) 10090
751 5GS0 5 L, Y light chain (anti-Lid) 10090
752 5G5X 2 B NANOBODY NB330, SELECTED FROM LLAMA, C-TERMINAL 6XHIS- TAG 9844
753 1KYO 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT RESIDUES 1-127 10090
754 1KYO 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT RESIDUES 1-107 10090
755 5GRJ 1 H avelumab H chain 9606
756 5GRJ 2 L avelumab L chain 9606
757 4NKD 1 A, C, E, G Engineered scFv heavy chain 10090
758 4NKD 2 B, D, F, H Engineered scFv light chain 10090
759 5BOZ 2 G, H, I, J, K, L VHH single chain antibody E1 30538
760 4KRO 2 B Nanobody/VHH domain EgA1 9844
761 3WXV 2 H V region heavy chain 10090
762 3WXV 3 L V region light chain 10090
763 1AR2 1 A REI VARIABLE REGION, LIGHT CHAIN 9606
764 4KV5 2 E, G, H, J heavy chain GC1009 scFv 9606
765 4KV5 3 F, I, K, L light chain GC1009 scFv 9606
766 3DWT 1 A, B, C, D, E, F, G, H cAbBCII-10 9838
767 5TJW 2 K NP-specific inhibitory VHH 30538
768 1QLE 5 H HEAVY CHAIN ANTIBODY FV FRAGMENT 10090
769 1QLE 6 L LIGHT CHAIN ANTIBODY FV FRAGMENT 10090
770 4LDL 2 B Camelid Antibody Fragment 9844
771 3E3Q 3 C, D, I, M, R, V, Z, d T-cell receptor alpha chain V region PHDS58 10090
772 5XP1 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 UNP residues 22-117 9606
773 4LDO 2 B Camelid Antibody Fragment 9844
774 5XJ3 1 A, D, G, J ipilimumab-VH 9606
775 5XJ3 2 B, E, H, K ipilimumab-VL 9606
776 3SN6 5 N Camelid antibody VHH fragment 9844
777 5M94 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
778 4M8Q 1 A, H GEP1 Fv heavy chain 9606
779 4M8Q 2 B, L GEP1 Fv light chain UNP residues 21-129 9606
780 5NHR 1 B, L Bimagrumab Fv Light-Chain VL domain LIGAND BINDING domain 9606
781 5NHR 2 A, H Bimagrumab Fv heavy-chain VH 9606
782 4W2O 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
783 5O8F 2 K, O Nanobody Nb25 9844
784 5O8F 3 L, M, N Nanobody Nb25 9844
785 5NQW 2 C, D 026 9844
786 5C3L 4 D Nanobody Nb15 Nanobody 9838
787 5J3H 2 C mAb 83-7 Fab heavy chain 10090
788 5J3H 3 D mAb 83-7 Fab light chain 10090
789 5U8R 2 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
790 5U8R 3 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
791 1G6V 2 K ANTIBODY HEAVY CHAIN CAB-CA05, VARIABLE DOMAIN 9838
792 5UK4 2 a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition mofiv and HIS TAG 30538
793 5FV2 1 A, B, C VH DOMAIN ANTIBODY VH DOMAIN ANTIBODY 9606
794 4WGV 2 B, D Camelid antibody fragment, nanobody 9844
795 5OJM 2 K, L, M, N, O Nanobody Nb25 9844
796 6B73 2 C, D Nanobody 9844
797 4PIR 2 F, G, H, I, J VHH15 9844
798 5XWD 2 H VH chain of 059-152 9606
799 5XWD 3 D VL chain of 059-152 9606
800 4QKX 2 B R9 protein 9844
801 5JQH 2 C, D Nanobody60, Nb60 9844
802 4YBQ 2 C, E antibody Fv fragment light chain 10090
803 4YBQ 3 D, F antibody Fv fragment heavy chain 10090
804 4PD4 10 J Igh protein 10090
805 4PD4 11 K Ig kappa chain V-V region HP 124E1 10090
806 5DA0 2 B Nanobody 9844
807 4R0L 1 A, H Antibody 1C6 Heavy chain 10090
808 4R0L 3 B, L Antibody 1C6 Light chain UNP residues 20-137 10090
809 5U8Q 3 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
810 5U8Q 4 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
811 3P0G 2 B Camelid Antibody Fragment NANOBODY 9844
812 4ODX 2 A, H GEP7 Fv heavy chain 9606
813 4ODX 3 B, L GEP7 Fv light chain 9606
814 5M95 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
815 4WGW 2 B, D Camelid antibody fragment, nanobody 9844
816 3E2H 3 B T-cell receptor alpha chain V region PHDS58 10090
817 4H1L 4 G, I Ani2.3 TCR A chain 562
818 1RVF 5 L FAB 17-IA 10090
819 1RVF 6 H FAB 17-IA 10090
820 5JZ7 2 C, G, H, J MEDI578 scFv, heavy chain 9606
821 5JZ7 3 D, I, K, L MEDI578 scFv, light chain 9606
822 5IHL 2 B, E, G, I 3H56-5 domain antibody (dAb) 3H56-5 dAb 9606
823 4MQS 2 B Nanobody 9-8 9844
824 5DHY 1 A, H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
825 5DHY 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
826 1QFW 3 L ANTIBODY (ANTI ALPHA SUBUNIT) (LIGHT CHAIN) FV 10090
827 1QFW 4 H ANTIBODY (ANTI ALPHA SUBUNIT) (HEAVY CHAIN) FV 10090
828 1QFW 5 M ANTIBODY (ANTI BETA SUBUNIT) (LIGHT CHAIN) FV 10090
829 1QFW 6 I ANTIBODY (ANTI BETA SUBUNIT) (HEAVY CHAIN) FV 10090
830 3K81 2 A, B Single strand antibody VHH domain single domain antibody VHH 9844
831 4OGA 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
832 4OGA 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
833 4MQT 2 B Nanobody 9-8 9844
834 5TOK 2 D, E, F Single-domain antibody F-VHH-L66 9844
835 4NKM 1 A, C, E, G Engineered scFv heavy chain 10090
836 4NKM 2 B, D, F, H Engineered scFv light chain 10090
837 3W11 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
838 3W11 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
839 4NKO 1 A, C, E Engineered scFv light chain 10090
840 4NKO 2 B, D, F Engineered scFv heavy chain 10090
841 5EUL 4 V AYC08 30538
842 5GXB 2 B nanobody 30538
843 5NBD 2 C Nanobody 9844
844 3W13 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
845 3W13 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
846 3W12 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
847 3W12 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
848 5H8O 1 A VHH nanobody 9844
849 4KSD 2 B R2 protein 9844
850 5DHZ 1 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
851 5DHZ 2 L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
852 2A0L 2 C, E 33H1 Fv fragment Fv fragment,light chain 10090
853 2A0L 3 D, F 33H1 Fv fragment Fv fragment, heavy chain 10090
854 5DFZ 4 E Nanobody binding S. cerevisiae Vps34 9844
855 5UKB 1 a, b, c, d, e Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition motif and HIS tag. 30538
856 5WDU 2 D, O, W bnAb NIH45-46 scFv heavy chain 9606
857 5WDU 3 E, P, X bnAb NIH45-46 scFv light chain 9606
858 5TD8 5 E nanobody 30538
859 6BSP 1 A U4 Heavy chain 10090
860 6BSP 2 B U4 Light chain 10090
861 6B3J 6 N Nanobody 35 9844
862 6EHG 3 C hC3Nb1 9844
863 5Y0A 2 D, F, H variable region of Fab ZKA190 heavy chain 9606
864 5Y0A 3 E, G, L variable region of Fab ZKA190 light chain 9606
865 5XS7 1 L Light chain of Fab 1D5 10090
866 5XS7 2 H Heavy chain of Fab 1D5 10090
867 5W3L 5 E C5 antibody variable heavy domain 10090
868 5W3L 6 G C5 antibody variable light domain 10090
869 5W3M 1 E C5 antibody variable heavy domain 10090
870 5W3M 2 G C5 antibody variable light domain 10090
871 5W3O 1 D C5 antibody variable heavy domain 10090
872 5W3O 2 E C5 antibody variable light domain 10090
873 5W3E 1 E C5 antibody variable heavy domain 10090
874 5W3E 2 G C5 antibody variable light domain 10090
875 5VAI 6 N nanobody 35 9844
876 5UZ7 4 N NANOBODY 35 9844
877 5TSJ 10 1, 2 Human heavy chain domain antibody 9606
878 5TR1 2 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
879 5TR1 3 L, M Monoclonal antibody, Fab fragment, light chain 10090
880 5TQQ 2 L, M Monoclonal antibody, Fab fragment, light chain 10090
881 5TQQ 3 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
882 5H32 2 G, I, K C10 IgG heavy chain variable region 9606
883 5H32 3 H, L, M C10 IgG light chain variable region 9606
884 5H37 3 G, I, K C10 IgG heavy chain variable region 9606
885 5H37 4 H, L, M C10 IgG light chain variable region 9606
886 5H30 3 G, I, K IgG C10 heavy chain 9606
887 5H30 4 H, L, M IgG C10 light chain 9606
888 5KWL 4 7 VHH 10E 9838
889 5KTZ 4 7 VHH 12B 9838
890 5KU0 4 7 VHH 17B 9838
891 5KU2 4 7 VHH 7A 9838
892 5KEL 3 H, P, Q c2G4 variable Fab domain heavy chain 9606
893 5KEL 4 L, T, U c2G4 variable Fab domain light chain 9606
894 5KEL 5 C, J, M c13C6 variable Fab domain heavy chain 9606
895 5KEL 6 D, N, O c13C6 variable Fab domain light chain 9606
896 5KEM 1 C, H BDBV91 variable Fab domain light chain 9606
897 5KEM 2 B, G BDBV91 variable Fab domain heavy chain 9606
898 5KEM 3 D, I c13C6 variable Fab domain heavy chain 9606
899 5KEM 4 E, J c13C6 variable Fab domain light chain 9606
900 5KEN 3 C, G, N c4G7 variable Fab domain heavy chain 9606
901 5KEN 4 D, H, O c4G7 variable Fab domain light chain 9606
902 5KEN 5 I, P c13C6 variable Fab domain light chain 9606
903 5KEN 6 J, Q c13C6 variable Fab domain heavy chain 9606
904 3JCX 2 H Fab E heavy chain 10116
905 3JCX 3 L Fab E light chain 10116
906 5FOJ 1 A NANOBODY 9838
907 3JBC 5 7 nanobody VHH PVSP29F 9838
908 3JBD 5 7 nanobody VHH PVSP6A 9838
909 3JBE 5 7 nanobody VHH PVSS8A 9838
910 3JBF 5 7 nanobody VHH PVSP19B 9838
911 3JBG 5 7 nanobody VHH PVSS21E 9838
912 3JBA 1 L H16.U4 antibody light chain Fab variable domain 10090
913 3JBA 2 H H16.U4 antibody heavy chain Fab variable domain 10090
914 3JAU 2 H Heavy chain of Fab fragment variable region of antibody D5 10090
915 3JAU 3 L Light chain of Fab fragment variable region of antibody D5 10090
916 5A1Z 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
917 5A1Z 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
918 4UIF 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 9606
919 4UIF 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 9606
920 4UIH 2 D, F ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -HEAVY CHAIN 9606
921 4UIH 3 E, G ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -LIGHT CHAIN 9606
922 4UDF 3 10, 14, 18, 1C, 1G, 1K, 1O, 1S, 1W, 20, 24, 28, 2C, 2G, 2K, 2O, 2S, 2W, 30, 34, 38, 3C, 3G, 3K, 3O, 3S, 3W, 40, 44, 48, 4C, 4G, 4K, 4O, 4S, 4W, 50, 54, 58, 5C, 5G, 5K, 5O, 5S, 5W, 60, 64, 68, 6C, 6G, 6K, 6O, 6S, 6W, 7C, 7G, 7K, 7O, 7S, 7W HUMAN MONOCLONAL ANTIBODY 9606
923 4UDF 4 11, 15, 19, 1D, 1H, 1L, 1P, 1T, 1X, 21, 25, 29, 2D, 2H, 2L, 2P, 2T, 2X, 31, 35, 39, 3D, 3H, 3L, 3P, 3T, 3X, 41, 45, 49, 4D, 4H, 4L, 4P, 4T, 4X, 51, 55, 59, 5D, 5H, 5L, 5P, 5T, 5X, 61, 65, 69, 6D, 6H, 6L, 6P, 6T, 6X, 7D, 7H, 7L, 7P, 7T, 7X HUMAN MONOCLONAL ANTIBODY 9606
924 3J8Z 2 J, K, L, M H16.1A light chain variable domain Fab 10090
925 3J8Z 3 F, G, H, I H16.1A heavy chain variable domain Fab 10090
926 3J8V 2 J, K, L, M H16.14J light chain variable domain Fab 10090
927 3J8V 3 F, G, H, I H16.14J heavy chain variable domain Fab 10090
928 3J8W 1 J, K, L, M H263.A2 light chain variable domain Fab 10090
929 3J8W 2 F, G, H, I H263.A2 heavy chain variable domain Fab 10090
930 3J7E 1 A, C, E, L H16.V5 Fab light chain variable domain 10090
931 3J7E 2 B, D, F, H H16.V5 Fab heavy chain variable domain 10090
932 3J6U 3 H Fab 5J7 heavy chain variable region 9606
933 3J6U 4 L Fab 5J7 light chain variable region 9606
934 2MMX 1 A V1-22 protein 9606
935 2MKW 1 A V1-22 protein 9606
936 4CKD 2 H, I, J, K SCFV13R4 ANTIBODY FV HEAVY CHAIN 10090
937 4CKD 3 L, M